Category: pharma & healthcare

Drug-Pricing “Experts” And CBO Underestimate The Threat To Innovation

The Congressional Budget Office and academic researchers ignore or misunderstand small companies when they analyze the impact of proposed price controls with potentially devastating consequences for new drug development.

Is An Artificial Pancreas On The Way?

A recent study shows real promise towards needle-free management of type 1 diabetes. In July, researchers published a paper describing the design of an artificial pancreas for children and adults with type 1 diabetes.

A Snapshot Of SARS-CoV-2 Evolution: Observed Increase Of Infectivity In The Covid-19 Virus

A recent scientific report underscores how rapidly SARS-CoV-2 adapts to selective pressure. The experiments examine how rapidly the virus can adapt to life in a Petri dish.

Beware Of Genetic Tests Evaluating Covid-19 Risk, Says New Study

The tests showed large variability even when analyzing data from the same person, leading experts to warn about their reliability.

Canadians End Up In ICU After Attending “Covid Party”

The party was held in the province of Alberta, which has declared a public health emergency as its hospitals struggle to cope with the surge in Covid-19 patients.

How SARS-CoV-2 Evades And Suppresses The Immune System (Part 13)

Today we turn our attention to the last remaining piece of the puzzle that is suppression of Covid-19 innate immune signaling: the M protein.

Bernie Sanders’ Price Controls On Drugs: A Simple Solution With Disastrous Implications For Innovation

Price controls on new drugs will kill innovation. Many of the treatments most urgently needed have yet to be developed.

A Missed Opportunity: A Decision To Regret

The FDA advisory panel made a mistake last Friday when it approved boosters only for those who are at high risk of severe Covid and those 65 and older.

Pandemic Cycles Of Covid-19: SARS-CoV-2 Immune Suppression Helps Us Understand Repeated Cycles Of Viral Infection And Vaccine Breakthrough

The more we understand what SARS-CoV-2 must do to evade our natural immune defenses, the more opportunities we have to create new ways to prevent and treat disease.

A New US/Japan Variant To Watch

A new variant has been detected in a Kentucky nursing home, infecting 45 residents and health care personnel. Many of these infections arose in fully vaccinated individuals. The variant, which originated in Japan, has over 10,000 entries in the GISAID …